Critical Reviews in Analytical Chemistry,
Год журнала:
2025,
Номер
unknown, С. 1 - 20
Опубликована: Май 19, 2025
Biological
toxins
are
metabolic
products
produced
by
living
organisms.
They
exert
deleterious
effects
on
another
organism
through
food,
drinking
water,
inhalation,
injection,
ingestion,
and
absorption
the
skin
or
mucous
membranes.
Health
such
as
respiratory
distress,
muscle
weakness,
seizures,
paralysis,
death
depend
amount
route
of
exposure
to
toxins.
act
quickly
fatal
even
in
low
doses,
can
be
considered
bioterror
agents
due
their
high
potency,
reasonably
long
latency
period
before
symptoms
exhibited,
difficulty
detecting
diagnosing
presence
identity,
relative
ease
production
stability
environment.
The
development
selective
sensitive
electrochemical
biosensors
has
been
main
importance
for
quantification
biological
amounts
samples.
This
review
examined
detection
various
toxin
using
aptasensors
immunosensors
from
2019
2025.
study
provided
information
effect
mechanism
organism,
modification
affinity
biosensors,
smartphone-based
portable
used
analysis
Frontiers in Pharmacology,
Год журнала:
2020,
Номер
11
Опубликована: Июль 24, 2020
Animal
poisons
and
venoms
are
comprised
of
different
classes
molecules
displaying
wide-ranging
pharmacological
activities.
This
review
aims
to
provide
an
in-depth
view
toxin-based
compounds
from
terrestrial
marine
organisms
used
as
diagnostic
tools,
experimental
validate
postulated
therapeutic
targets,
drug
libraries,
prototypes
for
the
design
drugs,
cosmeceuticals
agents.
However,
making
these
applicable
requires
extensive
preclinical
trials,
with
some
applications
also
demanding
clinical
in
order
their
molecular
target,
mechanism
action,
effective
dose,
potential
adverse
effects,
well
other
fundamental
parameters.
Here
we
go
through
pitfalls
a
become
eligible
trials
marketing.
The
manuscript
presents
overview
current
picture
several
animal
(such
those
amphibians,
cone
snails,
hymenopterans,
scorpions,
sea
anemones,
snakes,
spiders,
tetraodontiformes,
bats
shrews)
that
have
been
trials.
Advances
perspectives
on
underexploited
animals,
such
caterpillars
ticks,
reported.
challenges
faced
during
lengthy
costly
studies
how
overcome
hindrances
discussed
candidates
going
bedside.
It
covers
most
drugs
developed
using
toxins,
failed
currently
article
detailed
toxins
agents,
including
discovery,
formulation,
dosage,
indications,
main
effects
pregnancy
breastfeeding
prescription
warnings.
Toxins
diagnosis,
atypical
therapies
(bee
venom
leech
therapies)
level
cumulative
information
provided
this
may
help
pharmacists,
physicians,
biotechnologists,
pharmacologists
scientists
interested
toxinology,
discovery
development
products.
Briefings in Bioinformatics,
Год журнала:
2022,
Номер
23(5)
Опубликована: Апрель 20, 2022
Proteins/peptides
have
shown
to
be
promising
therapeutic
agents
for
a
variety
of
diseases.
However,
toxicity
is
one
the
obstacles
in
protein/peptide-based
therapy.
The
current
study
describes
web-based
tool,
ToxinPred2,
developed
predicting
proteins.
This
an
update
ToxinPred
mainly
peptides
and
small
method
has
been
trained,
tested
evaluated
on
three
datasets
curated
from
recent
release
SwissProt.
To
provide
unbiased
evaluation,
we
performed
internal
validation
80%
data
external
remaining
20%
data.
We
implemented
following
techniques
protein
toxicity;
(i)
Basic
Local
Alignment
Search
Tool-based
similarity,
(ii)
Motif-EmeRging
with
Classes-Identification-based
motif
search
(iii)
Prediction
models.
Similarity
motif-based
achieved
high
probability
correct
prediction
poor
sensitivity/coverage,
whereas
models
based
machine-learning
balance
sensitivity
specificity
reasonably
accuracy.
Finally,
hybrid
that
combined
all
approaches
maximum
area
under
receiver
operating
characteristic
curve
around
0.99
Matthews
correlation
coefficient
0.91
dataset.
In
addition,
alternate
realistic
datasets.
best
machine
learning
web
server
named
'ToxinPred2',
which
available
at
https://webs.iiitd.edu.in/raghava/toxinpred2/
standalone
version
https://github.com/raghavagps/toxinpred2.
general
proteins
regardless
their
source
origin.
Abstract
Venoms
have
evolved
>100
times
in
all
major
animal
groups,
and
their
components,
known
as
toxins,
been
fine-tuned
over
millions
of
years
into
highly
effective
biochemical
weapons.
There
are
many
outstanding
questions
on
the
evolution
toxin
arsenals,
such
how
venom
genes
originate,
contributes
to
fitness
venomous
species,
which
modifications
at
genomic,
transcriptomic,
protein
level
drive
evolution.
These
received
particularly
little
attention
outside
snakes,
cone
snails,
spiders,
scorpions.
Venom
compounds
further
become
a
source
inspiration
for
translational
research
using
diverse
bioactivities
various
applications.
We
highlight
here
recent
advances
new
strategies
modern
venomics
discuss
technological
innovations
multi-omic
methods
dramatically
improve
animals.
The
study
genomes
through
CRISPR
knockdown
technologies
will
increase
our
understanding
toxins
evolve
functions
they
different
ontogenetic
stages
during
development
Mass
spectrometry
imaging
combined
with
spatial
transcriptomics,
situ
hybridization
techniques,
computer
tomography
gives
us
insights
distribution
system
function
apparatus.
All
these
evolutionary
biological
contribute
more
efficiently
identify
compounds,
can
then
be
synthesized
or
produced
adapted
expression
systems
test
bioactivity.
Finally,
we
critically
agrochemical,
pharmaceutical,
therapeutic,
diagnostic
(so-called
translational)
aspects
venoms
from
humans
benefit.
Toxins,
Год журнала:
2021,
Номер
13(4), С. 292 - 292
Опубликована: Апрель 20, 2021
Climate
change
(CC)
is
predicted
to
increase
the
risk
of
aflatoxin
(AF)
contamination
in
maize,
as
highlighted
by
a
project
supported
EFSA
2009.
We
performed
comprehensive
literature
search
using
Scopus
engine
extract
peer-reviewed
studies
citing
this
study.
A
total
224
papers
were
identified
after
step
Cells,
Год журнала:
2023,
Номер
12(7), С. 986 - 986
Опубликована: Март 23, 2023
Continuous
monitoring
of
the
population’s
health
is
main
method
learning
about
disease
prevalence.
National
and
international
data
draw
attention
to
persistently
high
rates
cancer
incidence.
This
necessitates
intensification
efforts
aimed
at
developing
new,
more
effective
chemotherapeutic
chemopreventive
drugs.
Plants
represent
an
invaluable
source
natural
substances
with
versatile
medicinal
properties.
Multidirectional
activities
exhibited
by
their
ability
modulate
key
signaling
pathways,
mainly
related
cell
death,
make
these
important
research
direction.
review
summarizes
information
regarding
plant-derived
drugs,
including
mechanisms
action,
a
special
focus
on
selected
anti-cancer
drugs
(paclitaxel,
irinotecan)
approved
in
clinical
practice.
It
also
presents
promising
plant-based
drug
candidates
currently
being
tested
preclinical
trials
(betulinic
acid,
resveratrol,
roburic
acid).
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(12), С. 6742 - 6742
Опубликована: Июнь 19, 2024
Affinity
reagents,
or
target-binding
molecules,
are
quite
versatile
and
major
workhorses
in
molecular
biology
medicine.
Antibodies
the
most
famous
frequently
used
type
they
have
been
for
a
wide
range
of
applications,
including
laboratory
techniques,
diagnostics,
therapeutics.
However,
antibodies
not
only
available
affinity
reagents
do
significant
drawbacks,
laborious
costly
production.
Aptamers
one
potential
alternative
that
variety
unique
advantages.
They
single
stranded
DNA
RNA
molecules
can
be
selected
binding
to
many
targets
proteins,
carbohydrates,
small
molecules-for
which
typically
low
affinity.
There
also
cost-effective
methods
producing
modifying
nucleic
acids
vitro
without
cells,
whereas
require
cells
even
whole
animals.
While
there
drawbacks
using
aptamers
therapeutic
vivo
stability,
had
success
clinical
trials
treating
diseases
two
aptamer-based
drugs
gained
FDA
approval.
Aptamer
development
is
still
ongoing,
could
lead
additional
applications
aptamer
therapeutics,
antitoxins,
combinatorial
approaches
with
nanoparticles
other
acid
therapeutics
improve
efficacy.